In addition, Bachmayr-Heyda et al. [27] reported that the risk of mortality was more than three times higher among epithelial ovarian cancer patients with no Ki67+ cells than among those with Ki67+ cells (HR 3.34, 95% CI 1.59–7.04). This evidence concerns the gene MKI67 and ovarian carcinoma.